Suzhou Hongci Hematology Hospital

Suzhou Hongci Hematology Hospital is a specialized medical institution located in Suzhou, China, dedicated to the diagnosis and treatment of complex blood disorders and hematological malignancies. As a key member of the Hongci Healthcare Group, which is backed by CITIC Pacific, the hospital operates as one of the largest private hematology centers in the Yangtze River Delta region. The facility is renowned for its expertise in hematopoietic stem cell transplantation (HSCT) and the implementation of advanced cell therapies, including CAR-T cell treatments. It integrates clinical care with a robust research framework, serving as a site for numerous clinical trials for innovative oncology and hematology drugs. The hospital provides comprehensive services ranging from intensive chemotherapy to long-term management of bone marrow diseases and rare blood conditions.